Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, read with Company’s Code of Conduct for Prevention of Insider Trading, Bafna Pharmaceuticals has informed that the ‘Trading Window’ for dealing in the Company’s Securities by the Designated Persons of the Company and their immediate relatives, will remain closed from October 01, 2024 till 48 hours after the declaration of Un-audited Financial Results for the Second Quarter ending September 30, 2024. Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company’s securities during the aforesaid period of closure of Trading Window.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: